We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · July 07, 2021

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca Covid-19 Vaccines in Older Adults in England

BMJ : British Medical Journal


Additional Info

BMJ : British Medical Journal
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca Vaccines on Covid-19 Related Symptoms, Hospital Admissions, and Mortality in Older Adults in England: Test Negative Case-Control Study
BMJ 2021 May 13;373(xx)n1088, J Lopez Bernal, N Andrews, C Gower, C Robertson, J Stowe, E Tessier, R Simmons, S Cottrell, R Roberts, M O'Doherty, K Brown, C Cameron, D Stockton, J McMenamin, M Ramsay

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading